IL192299A0
(en )
2009-08-03
Use of nitrooxyderivative of drug for the treatment of muscular dystrophies
PL2601962T3
(en )
2020-02-28
LAG-3 dosage regime for use in the treatment of cancer
IL202014A0
(en )
2010-06-16
A synergistic pharmaceutical combination for the treatment of cancer
EP2166837A4
(en )
2011-12-21
Drug combination for the treatment of skin disorders
GB0602178D0
(en )
2006-03-15
Therapeutic treatment
PL1993577T3
(en )
2014-07-31
Use of non-digestable sacharides for giving an infant the best start after birth
IL184371A
(en )
2010-12-30
Use of an anti il-31ra antibody in the manufacture of a medicament for treating skin disorders
IL182104A
(en )
2010-11-30
Apparatus for altering the body temperature of a patient
IL182106A0
(en )
2007-07-24
Apparatus for altering the body temperature of a patient
IL188204A0
(en )
2008-03-20
Combination therapy for the treatment of immunoinflammatory disorders
HUE059861T2
(en )
2023-01-28
N-substituted 2,5-dioxo-azoline compounds for use in the treatment of cancer
SI2054088T1
(en )
2016-04-29
Device for the treatment of containers
GB0715790D0
(en )
2007-09-26
Drug combination for the treatment of sialorrhoea
IL200032A0
(en )
2010-04-15
Medicament for the treatment of endometriosis
GB0608655D0
(en )
2006-06-14
Therapeutic Treatment
IL192933A0
(en )
2009-02-11
Benzoisoindole derivatives for the treatment of pain
ZA200806949B
(en )
2009-10-28
Medicinal formulation for the treatment for hepatitis C
EP2222689A4
(en )
2011-11-30
Compounds for therapy and diagnosis
GB2427361B
(en )
2007-06-06
Treatment device for the human body
EP2005964A4
(en )
2011-01-05
The medicament for treating hyperphospheremia and preparation thereof
GB0610909D0
(en )
2006-07-12
Therapeutic treatment
SI1868614T1
(en )
2012-10-30
Dosage regimen for the treatment of a traumatic brain injury with progesterone
SI2030622T1
(en )
2011-04-29
Indication of dosage of progesterone in the treatment of a traumatic brain injury
IL193414A0
(en )
2009-05-04
Meridamycin analogues for the treatment ofneurodegenererative disorders
PL1714647T3
(en )
2011-05-31
Use of agomelatin in the manufacture of a medicament for the treatment of bipolar disorders